BIOMAT Database Logo BIOMAT Database Logo

[Cefpiramide, a new cephalosporin with high hepatic elimination; experimental evaluation of its biliary passage and disposition in the liver]. 1989

J M Brogard, and J F Blickle, and M Adloff, and F Jehl, and H Monteil
Département de Médecine Interne de la Clinique Médicale B, Centre Hospitalier Universitaire, Strasbourg.

The biliary elimination and hepatic disposition of cefpiramide were studied using an isolated and perfused rabbit liver model. Five experiments were performed, each lasting 3 hours. After addition of 10 mg of cefpiramide to the circulating blood, the biliary concentration reached a mean peak of 741 +/- 15 micrograms/ml between the 30th and 60th minute; the cumulated biliary elimination of the drug amounted 4042 +/- 1099 micrograms, corresponding to 40.4% of the injected dose. The hepato-biliary clearance was 54.5 ml/hr and the biliary elimination rate constant 0.2019(hr-1). At the end of the perfusion, 21.7% of the dose was still present in the circulating blood and 1.4% is found in the liver. Control experiments showed that 36.2% of the cefpiramide added into the experimental device was submitted to degradation. Thus, it was possible to calculate the rate of liver biotransformation of cefpiramide, which accounted for 0.3%. These experimental results confirm the major role of the liver in the elimination of cefpiramide and prove that the drug is not submitted to hepatic metabolisation.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001652 Bile Ducts The channels that collect and transport the bile secretion from the BILE CANALICULI, the smallest branch of the BILIARY TRACT in the LIVER, through the bile ductules, the bile ducts out the liver, and to the GALLBLADDER for storage. Bile Duct,Duct, Bile,Ducts, Bile
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

J M Brogard, and J F Blickle, and M Adloff, and F Jehl, and H Monteil
Biliary elimination and hepatic disposition of a new fluoroquinolone, temafloxacin: experimental evaluation.
January 1990, Drugs under experimental and clinical research,
J M Brogard, and J F Blickle, and M Adloff, and F Jehl, and H Monteil
Experimental efficacy and pharmacokinetic properties of cefpiramide, a new cephalosporin.
January 1985, Drugs under experimental and clinical research,
J M Brogard, and J F Blickle, and M Adloff, and F Jehl, and H Monteil
[Cefpiramide--a new cephalosporin antibiotic].
April 1994, Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic],
J M Brogard, and J F Blickle, and M Adloff, and F Jehl, and H Monteil
Comparative in vitro activity of cefpiramide, a new parenteral cephalosporin.
August 1988, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
J M Brogard, and J F Blickle, and M Adloff, and F Jehl, and H Monteil
[Absorption and elimination of a new cephalosporin].
May 1977, La Clinica terapeutica,
J M Brogard, and J F Blickle, and M Adloff, and F Jehl, and H Monteil
[Experimental study of new indomonocarbocyanins with selective biliary elimination].
May 1974, Biomedicine / [publiee pour l'A.A.I.C.I.G.],
J M Brogard, and J F Blickle, and M Adloff, and F Jehl, and H Monteil
[Experimental and clinical evaluation of cefpiramide in pediatrics].
August 1983, The Japanese journal of antibiotics,
J M Brogard, and J F Blickle, and M Adloff, and F Jehl, and H Monteil
[Experimental and clinical evaluation of cefpiramide in pediatrics].
August 1983, The Japanese journal of antibiotics,
J M Brogard, and J F Blickle, and M Adloff, and F Jehl, and H Monteil
[Experimental and clinical evaluation of cefpiramide in pediatrics].
August 1983, The Japanese journal of antibiotics,
J M Brogard, and J F Blickle, and M Adloff, and F Jehl, and H Monteil
[Experimental and clinical evaluation of cefpiramide in pediatrics].
August 1983, The Japanese journal of antibiotics,
Copied contents to your clipboard!